 GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore
GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore Dr Lal PathLabs Limited recommends 1:1 bonus issue
Dr Lal PathLabs Limited recommends 1:1 bonus issue RITES signs MoU with Shipping Corporation of India
RITES signs MoU with Shipping Corporation of India XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector
XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector Atishay Ltd empanelled as Business Associate with RailTel
Atishay Ltd empanelled as Business Associate with RailTel 
              Bombay Stock Exchange has announced that effective from October 19, 2007, the equity shares of Saamya Biotech India Ltd (Scrip Code: 532905) shall listed and admitted to dealings on the Exchange in the list of 'B1' Group Securities.
The company issued shares at a price of Rs.10 Per share (Face Value of Rs. 10/-) in the recently concluded IPO.
The ISIN Code of the company is INE320H01019.
Aarthi Consultants Private Limited is the Registrar to the issue.
DHIREN HASMUKHLAL VORA, PARK LIGHT INVESTMENT PRIVATE LIMITED, DEEP INFRASTRUCTURE PVT. LTD, MR. ASHVIN SOMCHAND SHETH, HARSHA RAJESH JHAVERI, VICKY R JHAVERI, PARMANAND GANPATRAM KHANDWALA, ELEGANT PROJECTS PVT LTD and RUPESH BALVANTBHAI BRAHMBHATT are the major shareholders of the company under Public Category.